- Home
- HTLD vs MYGN Comparison
HTLD vs MYGN Comparison
Compare HTLD & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTLD
- MYGN
- Stock Information
- Founded
- HTLD 1978
- MYGN 1991
- Country
- HTLD United States
- MYGN United States
- Employees
- HTLD N/A
- MYGN N/A
- Industry
- HTLD Trucking Freight/Courier Services
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- HTLD Industrials
- MYGN Health Care
- Exchange
- HTLD Nasdaq
- MYGN Nasdaq
- Market Cap
- HTLD 622.9M
- MYGN 642.0M
- IPO Year
- HTLD N/A
- MYGN 1995
- Fundamental
- Price
- HTLD $8.49
- MYGN $7.55
- Analyst Decision
- HTLD Hold
- MYGN Hold
- Analyst Count
- HTLD 5
- MYGN 13
- Target Price
- HTLD $9.70
- MYGN $13.50
- AVG Volume (30 Days)
- HTLD 624.9K
- MYGN 1.4M
- Earning Date
- HTLD 10-28-2025
- MYGN 11-06-2025
- Dividend Yield
- HTLD 0.94%
- MYGN N/A
- EPS Growth
- HTLD N/A
- MYGN N/A
- EPS
- HTLD N/A
- MYGN N/A
- Revenue
- HTLD $932,244,000.00
- MYGN $832,900,000.00
- Revenue This Year
- HTLD N/A
- MYGN $0.17
- Revenue Next Year
- HTLD $4.57
- MYGN $6.19
- P/E Ratio
- HTLD N/A
- MYGN N/A
- Revenue Growth
- HTLD N/A
- MYGN 3.83
- 52 Week Low
- HTLD $7.11
- MYGN $3.76
- 52 Week High
- HTLD $12.85
- MYGN $29.30
- Technical
- Relative Strength Index (RSI)
- HTLD 51.81
- MYGN 68.08
- Support Level
- HTLD N/A
- MYGN $7.13
- Resistance Level
- HTLD $8.81
- MYGN $7.80
- Average True Range (ATR)
- HTLD 0.22
- MYGN 0.42
- MACD
- HTLD -0.32
- MYGN 0.06
- Stochastic Oscillator
- HTLD 96.58
- MYGN 84.16
About HTLD Heartland Express Inc.
Heartland Express Inc is engaged in providing truckload services across the United States, Mexico, and Canada. These truckload services are asset-based transportation services in the dry van truckload market. The company offers truckload temperature-controlled transportation services, and Mexico logistics services. A majority of its customers represent the consumer goods, appliances, food products, and automotive industries.
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.